Merck acquired the target/assets from Cidara Therapeutics in an acquisition. Date of the transaction is not available.
Deal value was 9200000000 Sector: Healthcare; Location: USA.
On the acquirer side, legal advice was provided by a team including Roy Tannenbaum, Philip Richter, Saee Muzumdar, Sebastian Fain, Pamela Lawrence Endreny, Michael Collins, Karen Spindler, Meghan Hungate, Steve Weissman, Bradley Smith, Rama Padmanabhan, Charles Bair, Jane Adams, Rowook Park, Barbara Borden, Julia Kim.
Generated by AI, original source from - Data is in progress
Cidara Therapeutics advisor
Firm name is in progress
Found it useful? Spread the word.
Gibson Dunn advises Merck on its $9.2 billion acquisition of Cidara Therapeutics, with Cooley representing Cidara. | The Sponsor - The Sponsor
